Specific Stimulation Mode Electroacupuncture Combined With NGF for Recovery Period of Ischemic Stroke:Protocol for a Randomized Controlled Clinical Trial

Who is this study for? Patients with Acute Ischemic Stroke
Status: Recruiting
Location: See location...
Intervention Type: Device, Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY

Ischemic stroke is a common clinical disease, often accompanied by motor dysfunction and cognitive impairment. At present, clinical treatment for patients with ischemic stroke recovery is limited and ineffective. The emergence of NGF has surprised the field of neurorehabilitation, but the clinical effect is not satisfactory. The main problem is that NGF is a macromolecular material with a molecular weight of 13.4 KD, which is difficult to penetrate the blood brain barrier. A large number of previous studies in our team have found that electroacupuncture with specific stimulation mode can open the blood brain barrier and induce NGF into the brain。Therefore, the purpose of this study is to investigate the effect of specific stimulation mode electroacupuncture combined with NGF treatment together with rehabilitation training on patients with ischemic stroke recovery period and to explore the mechanism of this combination therapy to improve brain function, which creates a new method and theoretical basis for nerve rehabilitation of integrated traditional Chinese and Western medicine.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Maximum Age: 80
Healthy Volunteers: f
View:

• people with first-ever ischemic stroke confirmed by CT or/and MRI;

• 14 days to 6 months after stroke onset;

• 50 years≤aged≤80 years;

• 3≤modified Rankin Score (mRS)≤4, and Mini-Mental State Examinations (MMSE)\<27;

• Patients can accept treatment with EA and have good compliance;

• Patients have clear consciousness, pain perception and resolution ability to complete basic communication;

• willing to participate and be randomized to one of the groups.

Locations
Other Locations
China
The Third Affiliated Hospital of Zhejiang Chinese Medical University
RECRUITING
Hangzhou
Contact Information
Primary
xianming Lin, PHD
linxianming1966@163.com
+86-13858028101
Backup
yibin Zhao, PHD
510496772@qq.com
+86-15757195003
Time Frame
Start Date: 2022-04-01
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 288
Treatments
Other: sham EA + placebo group
sham EA + placebo group contain sham EA intervention and placebo injection
Other: sham EA + NGF group
sham EA + NGF group contain sham EA intervention and NGF injection
Other: EA + placebo group
EA + placebo group contain EA intervention and placebo injection
Other: EA + NGF group
EA + NGF group contain EA intervention and NGF injection
Related Therapeutic Areas
Sponsors
Leads: The Third Affiliated hospital of Zhejiang Chinese Medical University
Collaborators: Ningbo No.2 Hospital, second people hospital of lishui

This content was sourced from clinicaltrials.gov